Menu
Back to User profile » Dr Linlin Wang
Papers published by Dr Linlin Wang:
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
Mu F, Fan B, Li B, Qin W, Li H, Wang C, Zou B, Wang S, Wang L
Cancer Management and Research 2023, 15:351-362
Published Date: 12 April 2023
Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer
Duan Y, Qin W, Yang L, Zou B, Qie W, Song R, Xue L, Wang L
Cancer Management and Research 2023, 15:55-65
Published Date: 14 January 2023
Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report
Qin W, Zou B, Fan X, Fan B, Wang S, Wang L
Cancer Management and Research 2022, 14:1595-1602
Published Date: 29 April 2022
Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer
Li B, Jiang C, Wang R, Zou B, Xie P, Li W, Sun X, Yu J, Wang L
OncoTargets and Therapy 2020, 13:9043-9057
Published Date: 11 September 2020
Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases
Shang S, Su Y, Zhu Z, Li B, Guo M, Xu Y, Sun X, Wang L, Yu J
Cancer Management and Research 2018, 10:6421-6429
Published Date: 27 November 2018
Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC
Li B, Li C, Guo M, Shang S, Li X, Xie P, Sun X, Yu J, Wang L
OncoTargets and Therapy 2018, 11:6287-6294
Published Date: 27 September 2018
Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review
Bao Y, Liu Z, Guo M, Li B, Sun X, Wang L
Cancer Management and Research 2018, 10:1461-1470
Published Date: 8 June 2018